Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Maharashtra FDA cancels Johnson & Johnson baby powder manufacturing license

by AIP Online Bureau | Sep 17, 2022 | Health, Indian News, Policy, Regulation

The press note said that the samples of Johnson’s Baby Powder were declared “Not of Standard Quality”. FDA Maharashtra had taken the samples of Johnson’s Baby Powder at Pune and Nashik for quality check purposes Mumbai: Food & Drugs...
Next Entries »

Recent Posts

  • RBI flags AI-Powered cyberattacks as biggest threat to banks, NBFCs
  • IRDAI issues license to Prudential HCL Health Insurance
  • Hormuz half-open: tanker fleet prices in recovery hope
  • Australian consumer regulator sues Amazon over Prime Video advertising
  • Stop miscommunicating, build trust, not fear, to achieve insurance for All: Seth urges life insurers

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy